An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States

NCT06321055 · clinicaltrials.gov ↗

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastrointestinal Stromal Tumor

Interventions

DRUG: Regorafenib (Stivarga, BAY73-4506)

Sponsor

Bayer